Insulet Corp. buy BiotechBee
Start price
08.09.24
/
70%
€196.45
Target price
31.03.27
€230.00
Performance (%)
29.75%
End price
14.12.24
€254.90
Summary
This prediction ended on 14.12.24 with a price of €254.90. The prediction had a final performance of 29.75%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insulet Corp. | 2.367% | 2.367% | -41.693% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
According to BiotechBee what are the pros and cons of Insulet Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Insulet Corp. diskutieren
Buy mit Kursziel 230,0